Glenn van Langenhove, MD, PhD for the DELAYED RRISC (Dea
Articles
Late mortality with sirolimus-eluting stents in diseased saphenous vein grafts
Pierfrancesco Agostoni, MD;Paul Vermeersch, MD;Stefan Verheye, MD, PhD;Paul van den Heuvel, MD;Carl Convens, MD;Frank van den Branden, MD;Glenn van Langenhove, MD, PhD for the DELAYED RRISC (Dea
September 5th 2008In a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: November 21st 2024 | Updated: November 23rd 2024
Open-Label Study Finds Aficamten Could Help Most oHCM Patients Avoid Surgery
Published: October 9th 2014 | Updated: November 23rd 2024
Widespread "Yellow Bumps"
Published: November 19th 2024 | Updated: November 23rd 2024
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
Published: November 18th 2024 | Updated: November 23rd 2024
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
